InvestorsHub Logo
Followers 3
Posts 598
Boards Moderated 0
Alias Born 10/19/2016

Re: None

Thursday, 04/19/2018 5:58:02 PM

Thursday, April 19, 2018 5:58:02 PM

Post# of 6401
If I had never heard of this company before todays news detailing results of recent studies on uterine cancer in mice, I would start my due diligence and probably be inclined to buy some shares. The future could be bright with this promising clinical pipeline of drugs.

But since I bought shares in 2009 at .25 and the price (corrected for reverse split) is about .19, I can look at this as a failed experience. Notice that the board members were rewarded again with additional options for the work they have done that destroyed our investment. I cannot see any justification for buying back in but it is possible now that they could find a buyer.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent BPTH News